Mainstay of Treatment for Myeloma, Dexamethasone, Shows Very Significant Survival Benefit for COVID-19 Patients

Updated June 23rd, 2020

Mainstay of Treatment for Myeloma, Dexamethasone, Shows Very Significant Survival Benefit for COVID-19 Patients

NOW
PLAYING
49ers Linebackers Coach Johnny Holland Has Multiple Myeloma Relapse; Understanding This Rare Blood Cancer
NOW
PLAYING
A Leukemia Patient Unable to Get Vaccinated Has Died from COVID at 41; Should People with Blood Cancer Get the Vaccine?
NOW
PLAYING
Cameron Mathison Stars on 'General Hospital' After Kidney Cancer Diagnosis
NOW
PLAYING
COVID Vaccines Are Far Less Effective in Most Cancer Patients, Ineffective in Some, According to New Research
NOW
PLAYING
FDA: Risks to Myeloma Patients Taking Pepaxto After Deaths in Trial
NOW
PLAYING
Mark Hoppus Felt Terrible, Had 'Chemo Brain' After Last Cancer Treatment

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.